at Investor's Business Daily (Jan 20, 2015)
Johnson & Johnson (JNJ) voluntarily recalls 32M packages of its birth control pill Cilest in Europe, Asia and Latin America after tests reportedly showed that one of the two hormones in the product was being released more slowly than intended. J&J says that one of Cilest's active ingredients did not lead to "defined specification." J&J adds that the pill, which is not sold in the U.S., remains safe and effective.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 20, 2015)
at CNBC.com (Jan 20, 2015)
Pre-Market Earnings Report for January 20, 2015 : JNJ, MS, DAL, HAL, BHI, MTB, RF, IGTE, ATI, EDU, MTG, SAPat Nasdaq.com (Jan 16, 2015)
at CNBC.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs